Create Free Account

By creating account you will get access to hot stocks & personalised emails

Capitol Health Ltd

Healthcare AU CAJ

0.24AUD
-0.005(2.04%)

Last update at 2024-05-02T06:10:00Z

Day Range

0.240.25
LowHigh

52 Week Range

0.180.29
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -10.07400M 15.95M 19.44M 2.16M 31.40M
Minority interest -0.12000M -0.23600M 0.29M 0.22M 0.22M
Net income -11.39300M 10.73M 11.92M 0.86M 27.53M
Selling general administrative 141.11M 119.35M 107.00M 96.05M 101.99M
Selling and marketing expenses - - - - -
Gross profit 45.61M 45.80M 46.33M 34.89M 149.14M
Reconciled depreciation 24.75M 21.06M 21.40M 26.02M 8.90M
Ebit 14.42M 20.12M 22.85M 10.05M 12.93M
Ebitda 39.17M 41.18M 44.24M 36.08M 21.83M
Depreciation and amortization 24.75M 21.06M 21.40M 26.02M 8.90M
Non operating income net other - - - - -
Operating income 15.44M 20.07M 20.03M 10.63M 12.93M
Other operating expenses 110.98M 111.28M 107.99M 89.55M 132.11M
Interest expense 3.21M 1.04M 1.41M 3.21M 1.45M
Tax provision 1.20M 4.98M 7.41M 1.07M 3.86M
Interest income 4.14M 1.12M 0.01M 3.39M 1.62M
Net interest income -4.87500M -2.90600M -3.37800M -3.18900M -1.36100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.20M 4.98M 7.41M 1.07M 3.86M
Total revenue 208.50M 184.09M 177.92M 153.61M 149.14M
Total operating expenses 193.85M 163.96M 151.29M 143.46M 132.11M
Cost of revenue 162.88M 138.29M 131.59M 118.72M 112.25M
Total other income expense net -19.84300M -1.26800M -3.80200M -4.48800M 18.46M
Discontinued operations - - - - -
Net income from continuing ops -11.27300M 10.97M 12.03M 1.09M 27.53M
Net income applicable to common shares -11.39300M 10.73M 11.92M 0.86M 24.31M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 318.19M 271.19M 279.76M 262.31M 188.12M
Intangible assets 16.88M 7.06M 8.26M 8.23M 4.69M
Earning assets - - - - -
Other current assets 2.26M 0.74M 0.79M 0.77M 0.68M
Total liab 180.11M 117.14M 133.73M 118.27M 72.48M
Total stockholder equity 137.09M 153.00M 145.74M 143.82M 115.63M
Deferred long term liab - - - - -
Other current liab 0.70M 30.39M 36.31M 38.22M 22.05M
Common stock 160.16M 153.75M 148.63M 145.78M 107.63M
Capital stock 160.16M 153.75M 148.63M 145.78M 107.63M
Retained earnings -25.77800M -1.79300M -2.99300M -4.65400M 6.63M
Other liab 8.30M 12.74M 11.85M 8.38M 4.21M
Good will 157.29M 118.05M 117.78M 109.72M 102.60M
Other assets 0.22M 5.62M 5.83M 6.37M 5.67M
Cash 19.12M 13.38M 21.75M 13.76M 7.33M
Cash and equivalents - - - - -
Total current liabilities 48.39M 33.54M 37.60M 40.19M 24.62M
Current deferred revenue 27.80M -10.34600M -9.67800M -9.64000M -
Net debt 115.93M 67.82M 72.32M 65.58M 38.33M
Short term debt 11.62M 10.35M 9.78M 9.64M 2.00M
Short long term debt - - - - -
Short long term debt total 135.05M 81.21M 94.07M 79.34M 45.66M
Other stockholder equity -134.38700M -151.95600M -145.63800M -141.12200M 1.37M
Property plant equipment 114.38M 101.17M 100.09M 95.55M 42.54M
Total current assets 27.47M 20.11M 28.29M 20.30M 12.20M
Long term investments 1.95M 19.18M 19.52M 22.14M 20.41M
Net tangible assets -37.08600M 27.89M 19.70M 25.87M 9.21M
Short term investments 0.10M 0.11M 0.17M 0.28M 0.26M
Net receivables 5.99M 4.70M 5.58M 5.49M 2.66M
Long term debt 72.80M 19.00M 29.00M 17.00M 38.75M
Inventory - 1.18M - - 1.27M
Accounts payable 8.27M 3.15M 1.19M 1.97M 0.56M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.71M 1.05M 0.10M 2.69M 1.37M
Additional paid in capital - - - - -
Common stock total equity - - - 145.78M 107.63M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -290.51200M 0.29M 0.18M 0.63M 1.17M
Deferred long term asset charges - - - - -
Non current assets total 290.73M 251.08M 251.47M 242.01M 175.91M
Capital lease obligations 62.25M 62.21M 65.07M 62.34M 6.91M
Long term debt total 123.42M 70.86M 84.28M 69.70M 43.66M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -62.61800M -14.86800M -21.34400M -32.84500M -50.31500M
Change to liabilities 5.10M -2.21100M -3.36500M 6.34M 0.80M
Total cashflows from investing activities -62.61800M -14.86800M -21.34400M -32.84500M -50.31500M
Net borrowings 41.52M -20.03000M 2.30M -30.03300M 41.67M
Total cash from financing activities 30.81M -26.35700M -11.56100M 4.27M 27.18M
Change to operating activities -2.17100M -4.18200M 0.09M 4.02M 1.16M
Net income -11.39300M 10.73M 11.92M 0.86M 27.53M
Change in cash 5.73M -8.36500M 7.99M 6.43M -4.80700M
Begin period cash flow 13.38M 21.75M 13.76M 7.33M 12.14M
End period cash flow 19.12M 13.38M 21.75M 13.76M 7.33M
Total cash from operating activities 37.54M 31.86M 40.89M 35.01M 18.33M
Issuance of capital stock - 4.27M 0.39M 38.50M 1.78M
Depreciation 24.32M 20.62M 21.40M 20.12M 8.90M
Other cashflows from investing activities -45.77600M -1.00000M -13.70200M -20.68000M -35.56800M
Dividends paid -10.71100M -10.59700M -14.25300M -3.84200M 6.61M
Change to inventory - - - - -
Change to account receivables -0.89900M 0.77M -0.08900M -2.83100M 0.99M
Sale purchase of stock 0.00000M 4.27M 0.39M -0.35700M -7.88200M
Other cashflows from financing activities 41.52M -20.03000M 2.30M -8.28300M 76.85M
Change to netincome 22.16M 6.69M 10.94M 6.49M -17.82100M
Capital expenditures 16.84M 13.17M 7.64M 12.16M 14.75M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.89900M 0.77M -0.08900M -2.83100M 0.09M
Stock based compensation 2.42M 1.26M 1.36M 0.72M -
Other non cash items 24.61M 0.51M 7.58M 14.02M -36.43400M
Free cash flow 20.70M 18.69M 33.25M 22.84M -14.74700M

Fundamentals

  • Previous Close 0.24
  • Market Cap261.18M
  • Volume10195738
  • P/E Ratio24.00
  • Dividend Yield4.17%
  • EBITDA26.68M
  • Revenue TTM229.28M
  • Revenue Per Share TTM0.22
  • Gross Profit TTM 46.71M
  • Diluted EPS TTM0.01

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CAJ
Capitol Health Ltd		 -0.005 2.04% 0.24 24.00 15.67 1.09 1.87 1.65 9.72
RHCPA
Ramsay Health Care Ltd Pref		 -0.34 0.32% 106.26 65.03 - 0.90 - - -
RHC
Ramsay Health Care Ltd		 -0.1 0.20% 50.98 56.02 23.81 0.75 2.61 1.45 12.91
SNZ
Summerset Group Holdings Ltd		 -0.1 0.96% 10.37 6.10 - 9.08 1.03 13.66 7.94
REG
Regis Healthcare Ltd		 -0.07 1.84% 3.73 - 24.57 1.34 256.72 4.74 6.26

Reports Covered

Stock Research & News

View All

Profile

Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy. It operated various clinics in Victoria, Tasmania, Western Australia, and South Australia under the Capital Radiology brand, as well as under the Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens' Imaging, Direct Radiology, and Future Medical Imaging Group brand names. The company was incorporated in 2005 and is headquartered in East Melbourne, Australia.

Capitol Health Ltd

288 Victoria Parade, East Melbourne, VIC, Australia, 3002

Key Executives

Name Title Year Born
Mr. Justin Samuel Walter MPH (JCU) CEO, MD & Director NA
Mr. Craig David Bremner Chief Financial Officer NA
Ms. Melanie Jaye Leydin B.Bus, C.A., CA Company Sec. 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.